Strategic Wealth Partners Ltd. decreased its stake in shares of The Clorox Company (NYSE:CLX – Get Rating) by 5.9% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,925 shares of the company’s stock after selling 1,435 shares during the quarter. Strategic Wealth Partners Ltd.’s holdings in Clorox were worth $3,187,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in CLX. Carl Stuart Investment Advisor Inc. acquired a new position in shares of Clorox during the 1st quarter worth approximately $28,000. Tcwp LLC acquired a new position in shares of Clorox during the 1st quarter worth approximately $30,000. Cyrus J. Lawrence LLC acquired a new position in shares of Clorox during the 1st quarter worth approximately $31,000. Glassman Wealth Services increased its position in shares of Clorox by 339.5% during the 4th quarter. Glassman Wealth Services now owns 189 shares of the company’s stock worth $33,000 after purchasing an additional 146 shares during the last quarter. Finally, Quent Capital LLC acquired a new position in shares of Clorox during the 4th quarter worth approximately $37,000. Institutional investors and hedge funds own 81.69% of the company’s stock.
Analyst Ratings Changes
CLX has been the topic of a number of research reports. JPMorgan Chase & Co. upped their price objective on Clorox from $127.00 to $132.00 in a report on Thursday, July 21st. Morgan Stanley cut their target price on Clorox from $137.00 to $130.00 and set an “underweight” rating for the company in a research report on Thursday, August 4th. Deutsche Bank Aktiengesellschaft cut their target price on Clorox from $145.00 to $132.00 and set a “hold” rating for the company in a research report on Tuesday, June 21st. UBS Group cut their target price on Clorox to $129.00 in a research report on Friday, July 22nd. Finally, Barclays upped their target price on Clorox from $93.00 to $101.00 and gave the company an “underweight” rating in a research report on Friday, August 19th. Nine equities research analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $130.67.
Clorox Trading Down 2.7 %
Clorox Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 12th. Stockholders of record on Wednesday, July 27th were paid a $1.18 dividend. This is a boost from Clorox’s previous quarterly dividend of $1.16. The ex-dividend date of this dividend was Tuesday, July 26th. This represents a $4.72 annualized dividend and a dividend yield of 3.28%. Clorox’s dividend payout ratio is presently 126.88%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States.
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- These 3 Reports Will Tell Us Much About the Current Economy
- Is Five Below Trying to Punch Too High?
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle’s FQ1 Report
- Three Value Stocks For A Volatile Market
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.